x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- CVDRemove CVD filter
Publication Date
Please choose a date range between 2021 and 2022.
Author
- Aikawa, Elena1
- Aikawa, Masanori1
- Bartoli-Leonard, Francesca1
- Chapurlat, Roland1
- Djousse, Luc1
- Fretts, Amanda M1
- Hoofnagle, Andrew N1
- Howard, Barbara V1
- Jensen, Paul N1
- King, Irena B1
- Lemaitre, Rozenn N1
- McKnight, Barbara1
- Pham, Tan1
- Pradhan, Aruna D1
- Siscovick, David S1
- Sitlani, Colleen M1
- Sotoodehnia, Nona1
- Szulc, Pawel1
- Turner, Mandy E1
- Umans, Jason1
- Zimmer, Jonas1
Keyword
- ACS1
- acute coronary syndrome1
- acute myocardial infarction1
- AMI1
- atherosclerosis1
- C-reactive protein1
- cardiovascular disease1
- Cardiovascular Health Study1
- Cer1
- ceramide1
- ceramides1
- CHD1
- CHS1
- cohort study1
- coronary heart disease1
- Cox proportional hazards1
- CRP1
- diabetes1
- dyslipidemia1
- HR1
- IHD1
- Lp(a)1
- National Heart, Lung, and Blood Institute1
- NHLBI1
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-oriented and Epidemiological ResearchOpen Access
Elevated lipoprotein(a) as a predictor for coronary events in older men
Journal of Lipid ResearchVol. 63Issue 8100242Published online: June 17, 2022- Francesca Bartoli-Leonard
- Mandy E. Turner
- Jonas Zimmer
- Roland Chapurlat
- Tan Pham
- Masanori Aikawa
- and others
Cited in Scopus: 1Elevated circulating lipoprotein (a) [Lp(a)] is associated with an increased risk of first and recurrent cardiovascular events; however, the effect of baseline Lp(a) levels on long-term outcomes in an elderly population is not well understood. The current single-center prospective study evaluated the association of Lp(a) levels with incident acute coronary syndrome to identify populations at risk of future events. Lp(a) concentration was assessed in 755 individuals (mean age of 71.9 years) within the community and followed for up to 8 years (median time to event, 4.5 years; interquartile range, 2.5–6.5 years). - Patient-oriented and Epidemiological ResearchOpen Access
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
Journal of Lipid ResearchVol. 62100119Published online: September 20, 2021- Amanda M. Fretts
- Paul N. Jensen
- Andrew N. Hoofnagle
- Barbara McKnight
- Barbara V. Howard
- Jason Umans
- and others
Cited in Scopus: 0Recent studies suggest that the type of saturated fatty acid bound to sphingolipids influences the biological activity of those sphingolipids. However, it is unknown whether associations of sphingolipids with diabetes may differ by the identity of bound lipid species. Here, we investigated associations of 15 ceramide (Cer) and SM species (i.e., all sphingolipids, measured with coefficient of variation less than 20%) with incident type 2 diabetes in the Cardiovascular Health Study (n = 3,645), a large cohort study of cardiovascular disease among elderly adults who were followed from 1989 to 2015.